Cost Consequence of Introducing Paliperidone Palmitate 3-Monthly For The Maintenance Treatment of Schizophrenia In The English National Health Service (NHS)

T Ming,A Bird,B Rao

doi:10.1016/j.jval.2017.08.1876

Cost Consequence of Introducing Paliperidone Palmitate 3-Monthly For The Maintenance Treatment of Schizophrenia In The English National Health Service (NHS)

T Ming, A Bird + Show 1 more

Open Access

https://doi.org/10.1016/j.jval.2017.08.1876

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Oct 1, 2017
License type: publisher-specific-oa

Affiliation: Janssen (United Kingdom)

#National Health Service #Paliperidone Palmitate 3-Monthly + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Cost Consequence of Introducing Paliperidone Palmitate 3-Monthly For The Maintenance Treatment of Schizophrenia In The English National Health Service (NHS)

Full Text